Control Bionics Ltd. (AU:CBL) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Control Bionics Ltd. announced a change in Director Damian Lismore’s indirect interest, with an acquisition of 42,380 ordinary shares and 79,286 options, bringing his total to 971,905 shares. This increase reflects the issuance of underwriting shares and options, valued at $2,966.60 for the shares acquired. Investors in Control Bionics may find this development significant as it demonstrates insider confidence in the company’s prospects.
For further insights into AU:CBL stock, check out TipRanks’ Stock Analysis page.